Avanafil for male erectile dysfunction: a systematic review and meta-analysis
Avanafil, a potent new selective phosphodiesterase type 5 (PDE5) inhibitor, has been developed for the treatment of erectile dysfunction (ED). We carried out a systematic review and meta-analysis to assess the efficacy and safety of this drug for the treatment of ED. A literature review was performe...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2014-06-01
|
| Serija: | Asian Journal of Andrology |
| Teme: | |
| Online pristup: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=3;spage=472;epage=477;aulast=Cui |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|